New drug discovery: extraordinary opportunities in an uncertain time.

作者: Michael S. Kinch , Richard Flath

DOI: 10.1016/J.DRUDIS.2014.12.008

关键词: Risk analysis (engineering)Public sectorSustainabilityValue (ethics)Private sectorBusinessDrug discoveryWork (electrical)

摘要: The way in which new medicines are discovered has irreversibly changed and the future sustainability of enterprise is characterized by an unprecedented period uncertainty. Herein, we convey that these changes provide opportunities for many different players within private public sectors to work together develop models ensure activities have had extraordinary impact; terms promoting health driving economic value. Specific examples experiments provided demonstrate some thinking will be needed continuation drug discovery.

参考文章(18)
Vivek Wadhwa, A Reverse Brain Drain Social Science Research Network. ,(2009)
F. S. Collins, Reengineering Translational Science: The Time Is Right Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002747
Michael S. Kinch, Janie Merkel, Sheila Umlauf, Trends in pharmaceutical targeting of clinical indications: 1930–2013 Drug Discovery Today. ,vol. 19, pp. 1682- 1685 ,(2014) , 10.1016/J.DRUDIS.2014.05.021
Till F. Schäberle, Ingrid M. Hack, Overcoming the current deadlock in antibiotic research Trends in Microbiology. ,vol. 22, pp. 165- 167 ,(2014) , 10.1016/J.TIM.2013.12.007
Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, Mark L. Rohrbaugh, The Role of Public-Sector Research in the Discovery of Drugs and Vaccines New England Journal of Medicine. ,vol. 364, pp. 535- 541 ,(2011) , 10.1056/NEJMSA1008268
Mariana Mazzucato, The Entrepreneurial State ,(2013)
Owen Barder, Michael Kremer, Heidi Williams, Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases The Economists' Voice. ,vol. 3, pp. 1- 6 ,(2006) , 10.2202/1553-3832.1144